Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) had its price target dropped by stock analysts at Bank of America ...

In this podcast, Motley Fool analysts Nick Sciple and Karl Theil join hosts Ricky Mulvey and Mary Long to discuss: Kroger 's business results. Why some investors are becoming more pessimistic about ...

ADBE earnings call for the period ending December 31, 2024.

My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Oracle ...

The media today is fixated on presenting the economic and emotional cases for and against tariffs. As a result, politicians ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

W hen Musk and his allies turned their attention to the FAA last month, they identified a problem: The communications ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

Q1 2025 Earnings Conference Call March 12, 2025 5:00 PM ETCompany ParticipantsSteve Day - SVP, DX CFO & Corporate ...

The world is experiencing a rapid increase in temperatures, with heat records broken almost daily, due to the now-undeniable ...

After years of public outcry and several lawsuits from grassroots environmental groups, Point Reyes National Seashore ...